SEGMENT REPORTING - Net Sales and Segment Profit (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2021 |
Jun. 30, 2020 |
Mar. 31, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Dec. 31, 2020 |
|
| Segment Reporting Information [Line Items] | ||||||
| Net Sales | $ 3,672,000 | $ 1,939,000 | $ 7,149,000 | $ 4,853,000 | ||
| Segment Profit (Loss) | 2,334,000 | 907,000 | 4,565,000 | 3,068,000 | ||
| Non-cash share based compensation | (4,873,000) | (713,000) | ||||
| Depreciation and amortization | (524,000) | (365,000) | (1,103,000) | (717,000) | ||
| Goodwill impairment | 0 | 0 | 0 | (1,682,000) | ||
| Loss from operations | (9,603,000) | (7,325,000) | (17,371,000) | (16,499,000) | ||
| Loss on fair value of derivative instrument | 0 | (13,000) | 0 | 0 | ||
| Loss (gain) on remeasurement of warrant liability | (1,176,000) | 0 | 3,675,000 | 0 | ||
| Loss on investments | 0 | 67,000 | 0 | 228,000 | ||
| Foreign exchange loss | 80,000 | 311,000 | 839,000 | 359,000 | ||
| Interest expense | 920,000 | 953,000 | 1,898,000 | 1,789,000 | ||
| Miscellaneous, net | (485,000) | 105,000 | (1,087,000) | 48,000 | ||
| Loss before loss from equity investment | (8,942,000) | (8,748,000) | (22,696,000) | (18,923,000) | ||
| Cannabinoid | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Goodwill impairment | 0 | |||||
| Non-Cannabinoid | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Goodwill impairment | $ (1,682,000) | (1,682,000) | ||||
| Operating Segments | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Net Sales | 3,672,000 | 1,939,000 | 7,149,000 | 4,853,000 | ||
| Segment Profit (Loss) | (2,970,000) | (4,521,000) | (5,222,000) | (9,442,000) | ||
| Long-lived assets | 28,704,000 | 28,704,000 | $ 25,680,000 | |||
| Operating Segments | Cannabinoid | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Net Sales | 579,000 | 153,000 | 1,256,000 | 395,000 | ||
| Segment Profit (Loss) | (3,604,000) | (4,454,000) | (6,468,000) | (9,855,000) | ||
| Long-lived assets | 28,528,000 | 28,528,000 | 25,485,000 | |||
| Operating Segments | Non-Cannabinoid | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Net Sales | 3,093,000 | 1,786,000 | 5,893,000 | 4,458,000 | ||
| Segment Profit (Loss) | 634,000 | (67,000) | 1,246,000 | 413,000 | ||
| Long-lived assets | 151,000 | 151,000 | 176,000 | |||
| Reconciliation | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Segment Profit (Loss) | (2,970,000) | (4,521,000) | (5,222,000) | (9,442,000) | ||
| Unallocated corporate expenses | (2,786,000) | (2,141,000) | (6,173,000) | (3,945,000) | ||
| Non-cash share based compensation | (3,323,000) | (297,000) | (4,873,000) | (713,000) | ||
| Depreciation and amortization | (524,000) | (365,000) | (1,103,000) | (717,000) | ||
| Goodwill impairment | 0 | 0 | 0 | (1,682,000) | ||
| Loss from operations | (9,603,000) | (7,325,000) | (17,371,000) | (16,499,000) | ||
| Loss on fair value of derivative instrument | 0 | (13,000) | 0 | 0 | ||
| Loss on investments | 0 | 67,000 | 0 | 228,000 | ||
| Foreign exchange loss | 80,000 | 311,000 | 839,000 | 359,000 | ||
| Interest expense | 920,000 | 953,000 | 1,898,000 | 1,789,000 | ||
| Miscellaneous, net | (485,000) | 105,000 | (1,087,000) | 48,000 | ||
| Loss before loss from equity investment | (8,942,000) | $ (8,748,000) | (22,696,000) | $ (18,923,000) | ||
| Other | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Long-lived assets | $ 25,000 | $ 25,000 | $ 19,000 | |||
| X | ||||||||||
- Definition Unallocated Corporate Expenses No definition available.
|
| X | ||||||||||
- Definition Warrant Liability, Remeasurement, Loss (Gain) No definition available.
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of nonoperating interest income (expense). No definition available.
|
| X | ||||||||||
- Definition Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|